Engineers Gate Manager’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $678K | Buy |
|
|||||
|
2025
Q1 | $345K | Sell |
|
|||||
|
2024
Q4 | $2.59M | Sell |
|
|||||
|
2024
Q3 | $8.83M | Buy |
|
|||||
|
2024
Q2 | $4.77M | Buy |
|
|||||
|
2024
Q1 | $2.36M | Buy |
|
|||||
|
2023
Q4 | $1.27M | Sell |
|
|||||
|
2023
Q3 | $2.57M | Buy |
|
|||||
|
2023
Q2 | $1.6M | Sell |
|
|||||
|
2023
Q1 | $1.79M | Buy |
|
|||||
|
2022
Q4 | $489K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $513K | Buy |
|
|||||
|
2022
Q1 | $349K | Buy |
|
|||||
|
2021
Q4 | $234K | Sell |
|
|||||
|
2021
Q3 | $638K | Sell |
|
|||||
|
2021
Q2 | $1.15M | Buy |
|
|||||
|
2020
Q4 | – | Sell |
|
|||||
|
2020
Q3 | $1.21M | Buy |
|
|||||
|
2020
Q2 | $443K | Buy |
|
|||||
|
2020
Q1 | $234K | Sell |
|
|||||
|
2019
Q4 | $2.59M | Buy |
|
|||||
|
2019
Q3 | $493K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $211K | Buy |
|